Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,131 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, not recruiting

Tislelizumab, Gemcitabine and Cisplatin for R/R Hodgkin Lymphoma Followed by Tislelizumab Consolidation in Patients in Metabolic Complete Remission

NCT05502250

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • BE-Bruxelles-STLUC Brussels, Belgium
  • DK-Aarhus N-AUH Aarhus, Denmark
  • DK-Copenhagen-RIGSHOSPITALET Copenhagen, Denmark
  • DK-Odense-OUH Odense, Denmark
View all 15 locations
View Trial Details
Active, not recruiting

Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients

NCT05306301

Conditions
Chemotherapy, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Ematologia con Unità di Trapianto Avellino, AV, Italy
  • Ematologia Presidio Ospedaliero Tortora Pagani, SA, Italy
  • Ematologia ASST Papa Giovanni XXIII Bergamo, Italy
  • Ematologia AOU S.ORSOLA-MALPIGHI Bologna, Italy
View all 24 locations
View Trial Details
Active, not recruiting

Zanubrutinib in Primary Cold Agglutinin Disease

NCT06067048

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • UZ leuven Leuven, Belgium
  • AZ Delta Roeselare, Belgium
  • Rigshospitalet Copenhagen, Denmark
  • Odense University Hospital Odense, Denmark
View Trial Details
Active, not recruiting

A Phase 1, Open-label, Multicenter, Dose Escalation Study of IBI363 (PD1-IL2m) in Subjects With Advanced Solid Malignancies or Lymphomas

NCT05290597

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • [email protected] Sydney, New South Wales, Australia
  • Westmead Hospital Sydney, New South Wales, Australia
  • Sydney Southwest Private Hospital Sydney, New South Wales, Australia
  • Cancer Care Wollongong Sydney, New South Wales, Australia
View Trial Details
Active, not recruiting

Belantamab Mafodotin in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients

NCT04802356

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hospital Son Llatzer Palma de Mallorca, Balearic Islands, Spain
  • Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain
  • Hospital Universitario de Salamanca Salamanca, Castille and León, Spain
  • Complejo Universitario Hospitalario de Santiago Santiago de Compostela, Galicia, Spain
View Trial Details
Active, not recruiting

A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation

NCT06045806

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Local Institution - 0131 Los Angeles, California, United States
  • Local Institution - 0126 Orange, California, United States
  • Local Institution - 0113 Sacramento, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 101 locations
View Trial Details

Related conditions